Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL248362 | 0.90 | — | — | |
| SCHEMBL290836 | 0.83 | — | — | |
| SCHEMBL929596 | 0.82 | — | — | |
| SCHEMBL2591666 | 0.78 | PRMT1 (0.31) | — | |
| SCHEMBL27888486 | 0.77 | MEN1 (0.46) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL5464884 | 0.77 | — | — | |
| Propylene Glycol SCHEMBL6009699 | 0.76 | HSD17B10 (0.32) | — | |
| SCHEMBL20301478 | 0.75 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL612218 | 0.73 | — | — | |
| SCHEMBL17027335 | 0.73 | MEN1 (0.41) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8846651-B2 | Lipid composition having excellent shape retention property and product | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-09-30 | — | — | US | claimed |
| EP-1761238-B1 | MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION COMPRISING THE SAME | TAKASAGO PERFUMERY CO LTD (JP) | 2012-09-05 | — | — | EP | claimed |
| US-20100093682-A1 | LIPID COMPOSITION HAVING EXCELLENT SHAPE RETENTION PROPERTY AND PRODUCT | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-04-15 | — | — | US | claimed |
| US-8846651-B2 | Lipid composition having excellent shape retention property and product | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-09-30 | — | — | US | disclosed |
| US-20130247654-A1 | METHOD FOR EVALUATING SENSORY STIMULUS COMPONENT | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-09-26 | — | — | US | disclosed |
| EP-2642287-A2 | Method for evaluating sensory stimulus component | Takasago International Corporation (JP) | 2013-09-25 | — | — | EP | disclosed |
| EP-1761238-B1 | MENTHOL DERIVATIVE AND COOLING AGENT COMPOSITION COMPRISING THE SAME | TAKASAGO PERFUMERY CO LTD (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-20110281945-A1 | GASTRIC ACID SECRETION INHIBITOR, AND POTASSIUM CHANNEL INHIBITOR | SHIZUOKA PREFECTURE PUBLIC UNIVERSITY CORPORATION (JP) | 2011-11-17 | — | — | US | disclosed |
| US-20100093682-A1 | LIPID COMPOSITION HAVING EXCELLENT SHAPE RETENTION PROPERTY AND PRODUCT | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100093682-A1 | LIPID COMPOSITION HAVING EXCELLENT SHAPE RETENTION PROPERTY AND PRODUCT | MGLL, LIPC, CETP | MEN1 353/4885KMT2A 2311/4885THRB 2302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.